Poradosu Enrique

Average Profitability
25.81%
Insider Buys Quantity
6
Insider Buys Sum
$56,029.20
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Poradosu Enrique

According to the SEC Form 4 filings, Poradosu Enrique, being in a position of

  1. Chief Science & Business Off at Nuvectis Pharma, Inc.,
    оver the last 12 months, has bought 2500 shares for $13,125, and sold 0 shares,
    over all time since 2022-02-04, has bought 12570 shares for $56,029, and sold 0 shares.

The largest purchase of all time was on 2022-02-04 and amounted to 7600 shares of Nuvectis Pharma, Inc. for $25,460.

Biography of Poradosu Enrique

No biography is available at this moment.

2024-11-19PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
2,000
0.0103%
$4.99$9,980+1.2%
2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
500
0.0027%
$6.29$3,145+3.52%
2023-03-27PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
500
0.0033%
$11.55$5,775+3.76%
2022-05-12PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
370
0.0024%
$14.76$5,461-48.66%
2022-02-07PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
1,600
0.0085%
$3.88$6,208+1.38%
2022-02-04PurchaseNuvectis Pharma, Inc.
NVCT
Chief Science & Business Off
7,600
0.0855%
$3.35$25,460+146.77%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.